Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.
about
Prevention of mother-to-child transmission of HIV Option B+ cascade in rural Tanzania: The One Stop Clinic modelIncidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study.Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy AdherencePrevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort.Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realizedImplementation and Operational Research: An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa.Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Burden of serious fungal infections in Tanzania.Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.A decade of HIV care in rural Tanzania: Trends in clinical outcomes and impact of clinic optimisation in an open, prospective cohort.Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program.HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for "Prevention Is Better Than Cure"?CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau.Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test.The war on cryptococcosis: A Review of the antifungal arsenal.Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda
P2860
Q33898494-4E9BE374-90E6-43FD-8EDA-41B8ED1191AAQ36300731-A932BCDC-1946-424B-9AF8-102A02316405Q36900055-9BF1DA4C-C413-4E18-9668-6D52773727FBQ37305541-04BDB068-31E8-464A-A0CF-55DB9073C30FQ37393668-53063454-1FA6-45FE-9DCB-859417EBE5D4Q37520078-A113B506-2EFE-43A0-9610-EDAADDA78BCEQ38851467-7E6D706C-269F-4E12-8EDE-92F3A6F55588Q38997873-96CE6708-9174-4241-A9B5-17ABB37A4E46Q39379643-5C4D49DB-F590-47A6-A7D9-86DF46CC1F33Q39553800-5C9DBF87-B025-4C08-9883-729D11EC76BFQ45326483-43B709D1-DEA1-4A89-977E-E32A66650657Q47646979-A5937756-D173-493F-91B3-F39DE6D969E5Q51365549-BB83DB8F-9DBC-40B3-A184-7872A0207A3BQ52584372-F6DFB984-8122-4B6E-8E4B-80CC060465A5Q52624536-9D09B9E4-94A4-45AD-A1D1-2F4074C63C06Q54260674-EA1B6599-6AFE-4869-A4EC-1D785D61BA44Q55229762-4A306ED1-5924-45D3-AC9B-0D9AE9A6FB94Q56912008-A328636A-755F-41B3-B6BD-25846B9EBEAD
P2860
Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cryptococcal Antigenemia in Im ...... able Cause of Early Mortality.
@ast
Cryptococcal Antigenemia in Im ...... able Cause of Early Mortality.
@en
type
label
Cryptococcal Antigenemia in Im ...... able Cause of Early Mortality.
@ast
Cryptococcal Antigenemia in Im ...... able Cause of Early Mortality.
@en
prefLabel
Cryptococcal Antigenemia in Im ...... able Cause of Early Mortality.
@ast
Cryptococcal Antigenemia in Im ...... able Cause of Early Mortality.
@en
P2093
P2860
P50
P356
P1476
Cryptococcal Antigenemia in Im ...... able Cause of Early Mortality.
@en
P2093
Alex J Ntamatungiro
Diana Faini
Matthias C Müller
Namvua Kimera
P2860
P304
P356
10.1093/OFID/OFV046
P50
P577
2015-04-02T00:00:00Z